← Back to Search

Ultrasound Therapy

Splenic Ultrasound for Rheumatoid Arthritis (ULTRA Trial)

N/A
Waitlist Available
Led By Erik Peterson, M.D.
Research Sponsored by SecondWave Systems Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study participation
Awards & highlights

ULTRA Trial Summary

This trial will assess whether or not spleen ultrasound stimulation is effective in treating rheumatoid arthritis in a pilot study.

Eligible Conditions
  • Rheumatoid Arthritis

ULTRA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Within-arm change in the Disease Activity Score (DAS-28-CRP) from baseline to the completion of an up-to 8-week treatment period.
Other outcome measures
Exit interview questions.
Within-arm change of serum Interferon gamma (IFN-gamma) concentration.
Within-arm change of serum Interleukin-1 beta (IL-1beta) concentration.
+8 more

ULTRA Trial Design

1Treatment groups
Experimental Treatment
Group I: Ultrasound GroupExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Splenic Ultrasound
2021
N/A
~80

Find a Location

Who is running the clinical trial?

SecondWave Systems Inc.Lead Sponsor
3 Previous Clinical Trials
113 Total Patients Enrolled
University of MinnesotaOTHER
1,379 Previous Clinical Trials
1,588,482 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
1,767 Patients Enrolled for Rheumatoid Arthritis
DARPA (United States Department of Defense)UNKNOWN
1 Previous Clinical Trials
58 Total Patients Enrolled

Media Library

Splenic Ultrasound (Ultrasound Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05417854 — N/A
Rheumatoid Arthritis Research Study Groups: Ultrasound Group
Rheumatoid Arthritis Clinical Trial 2023: Splenic Ultrasound Highlights & Side Effects. Trial Name: NCT05417854 — N/A
Splenic Ultrasound (Ultrasound Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05417854 — N/A
Rheumatoid Arthritis Patient Testimony for trial: Trial Name: NCT05417854 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the trial still open and inviting participants?

"As per the most recent update on clinicaltrials.gov, this trial is still engaging participants. It was initially publicised on June 29th 2022 and has since been revised."

Answered by AI

What is the current participation rate of this experiment?

"Affirmative. On clinicaltrials.gov, it is noted that the trial first posted on June 29th 2022 and was last modified on July 1st of the same year is actively recruiting for 15 participants across 2 sites."

Answered by AI

Who else is applying?

What state do they live in?
Kansas
Wisconsin
What site did they apply to?
University of Minnesota Health Clinics and Surgery Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I would like to find a method to get my RA under control. Because I am interested in alternative control of my disease.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]
2022. "Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05417854.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top